Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: sam who wrote (5256)	9/3/1998 4:18:00 PM
From: margie	Respond to of 6136

(AP) AIDS Researcher Among Jet Victims The Associated Press; September 3, 1998 Dr. Jonathan Mann, who became known as the outspoken head of the World Health Organization's AIDS program when the disease exploded in the 1980s, was among the 229 people killed in the crash of Swissair Flight 111. Mann, 51, was dean of Allegheny University of the Health Sciences' School of Public Health in Philadelphia, formerly known as Hahnemann University Hospital. Mann resigned in December from Harvard University's School of Public Health, where he was a professor of international health and epidemiology. He was also director of Harvard's Francois-Xavier Bagnoud Center of Health and Human Rights. The Boston native headed the WHO's AIDS program from 1986 until 1990, when he resigned amid a bitter clash with Hiroshi Nakajima, then WHO's director-general. Nakajima's attitude "completely paralyzed our efforts," Mann said then. "It's a terrific loss for the whole AIDS community because his name and voice are very familiar to anybody who works on this issue," Larry Kessler, executive director of the AIDS Action Committee of Boston, said of Mann's death. "I think his only regret was that he could never find enough money worldwide that would make a big enough dent in this epidemic," he said. Mary-Lou Clements-Mann, who was with her husband on the plane, also was a noted AIDS researcher who taught at Johns Hopkins University School of Public Health. She was working on developing AIDS vaccines. Mann had intended as a medical student to become an eye doctor, but fast became interested in public health when he went to New Mexico after graduation to work for the Centers for Disease Control. Two years later, in 1977, he moved to the state's public health department and held various positions, including state epidemiologist. He stayed in New Mexico for 10 years and was credited with helping control bubonic plague there. After that, Mann said he needed a change and took an offer to spend a year in Zaire setting up an AIDS research facility under the auspices of the WHO. A memorial observance was scheduled for today, Leclair said. Copyright 1998/The Associated Press. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Permissions Desk, The Associated Press, 50 Rockefeller Plaza, New York, NY 10020. (VAXGEN) Statement Relating to Victims of Swissair Crash BUSINESS WIRE; Thursday, September 3, 1998 SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Sept. 3, 1998--Dr. Donald P. Francis, President of VaxGen Inc., today issued the following statement regarding the deaths of Jonathan Mann and Mary Lou Clements-Mann in the Swissair crash: For me, this is a deep personal loss. I have known and admired both Jonathan Mann and Mary Lou Clements-Mann as personal friends and professional colleagues for many years. For the world, the loss is incalculable. Jonathan and Mary Lou were indefatigable workers and spokespersons in the battle to improve world health. They brought invaluable knowledge, skills and pioneering leadership to the greatest public health challenge of our day -- the AIDS epidemic. This leaves a great void on the front lines of medicine.